Assessment of Codispensing Patterns of Mirabegron and Prespecified CYP2D6 Substrates in Patients with Overactive Bladder

BACKGROUND: Patients with overactive bladder (OAB) experience sudden, intense urges to urinate, which may include urge urinary incontinence and nocturia. Pharmacotherapy includes β(3)-adrenergic receptor agonists such as mirabegron; however, mirabegron contains a label warning for cytochrome P450 (C...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Jingjun, Ritchey, Mary E., Reynolds, Kamika, Carbonneau, Madeleine, Carrera, Adam, Goti, Noelia, Horn, John R., Girman, Cynthia J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2023
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10491567/
https://www.ncbi.nlm.nih.gov/pubmed/37219800
http://dx.doi.org/10.1007/s40801-023-00370-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10491567/
https://www.ncbi.nlm.nih.gov/pubmed/37219800
http://dx.doi.org/10.1007/s40801-023-00370-6

Ejemplares similares